BRSK1
| Official symbol: | BRSK1 |
| Full name: | BR serine/threonine kinase 1 |
| Location: | 19q13.42 |
| Also known as: | KIAA1811 |
| Entrez ID: | 84446 |
| Ensembl ID: | ENSG00000160469 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.17 | | Gscore (Del): | 0.29 |
|
|
| Recurrently amplified in 1 cancer type(s) | | Recurrently deleted in 2 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 1 |
|
|
| Fusions detected in 1 cancer type(s) |
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 28.86 (Percentile rank: 53.39%) |
| PubTator score: | 31.25 (Percentile rank: 60.19%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
